5-(n,n-hexamethylene)amiloride has been researched along with Hepatocellular Carcinoma in 1 studies
5-(N,N-hexamethylene)amiloride: inhibitor of Na+-H+ exchange; has anti-HIV-1 activity
5-(N,N-hexamethylene)amiloride : A member of the class of pyrazines that is amiloride in which the two amino hydrogens at position N-5 are replaced by a hexamethylene moiety, resulting in the formation of an azepane ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Cañero, R | 1 |
| Trilla, C | 1 |
| Pérez de Diego, J | 1 |
| Díaz-Gil, JJ | 1 |
| Cobo, JM | 1 |
1 other study available for 5-(n,n-hexamethylene)amiloride and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Na+ :H+ exchange inhibition induces intracellular acidosis and differentially impairs cell growth and viability of human and rat hepatocarcinoma cells.
Topics: Acidosis; Amiloride; Animals; Antineoplastic Agents; Calcium; Carcinoma, Hepatocellular; Cell Divisi | 1999 |